Molecular targets for cystic fibrosis and therapeutic potential of monoclonal antibodies

Cystic fibrosis (CF) is a genetic disease that affects the exocrine glands and is caused by cystic fibrosis transmembrane conductance regulator gene (CFTR) mutations. Lung disease is the leading cause of morbidity in patients. Target-specific treatment of CF has been achieved using monoclonal antibo...

Descripción completa

Detalles Bibliográficos
Autores principales: Moni, Sivakumar S., Al Basheer, Asmaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805982/
https://www.ncbi.nlm.nih.gov/pubmed/36601503
http://dx.doi.org/10.1016/j.jsps.2022.10.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805982/
https://www.ncbi.nlm.nih.gov/pubmed/36601503
http://dx.doi.org/10.1016/j.jsps.2022.10.002

Ejemplares similares